Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
NCT05768269 · View on ClinicalTrials.gov ↗
Study Summary
This study is designed to collect long-term safety and survival data from participants previously treated in an eligible Century-sponsored index trial. This is an observational study, and the elements of the study design allow for important follow-up for safety, survival, and the continued evaluation of any late adverse events (AEs) that may appear after treatment with such cellular products. Additionally, collection of persistence data from participants will support the identification of any long-term risks or late AEs that may be causally related to treatment with such cellular products.
Conditions Studied
Interventions
- OTHER No Intervention
Study Locations (7)
Arizona
- Banner MD Anderson Cancer Center — Gilbert
California
- University of Southern California - Norris Comprehensive Cancer Center — Los Angeles
Maryland
- University of Maryland Medical Center — Baltimore
Michigan
- Corewell Health — Grand Rapids
North Carolina
- Levine Cancer Institute — Charlotte
Ohio
- University of Cincinnati Medical Center — Cincinnati
Washington
- Swedish Cancer Institute — Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2024-04-29 |
| Est. Completion | 2040-03 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05768269
The ClinicalTrials.gov registry entry for NCT05768269 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 375 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Century Therapeutics, which has 2 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Hematological Malignancy appearing as the primary indexed condition, and to 1 intervention — of which No Intervention is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05768269 reports 7 study locations spanning 7 distinct geographic areas — top geographies include Arizona, California, Maryland. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05768269 about?
NCT05768269 is a clinical study titled "A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product". This study is designed to collect long-term safety and survival data from participants previously treated in an eligible Century-sponsored index trial. This is an observational study, and the elements of the study design allow for important follow-up for safety, survival, and the continued evaluatio...
What is the current status of trial NCT05768269?
This trial is currently recruiting. The enrollment target is 375 participants. The study started on 2024-04-29. Estimated completion is 2040-03.
What conditions does trial NCT05768269 study?
This clinical trial studies the following conditions: Hematological Malignancy, Solid Tumor Malignancy. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT05768269?
The interventions under investigation include: No Intervention (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT05768269?
This trial is sponsored by Century Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05768269 being conducted?
This trial has 7 study locations across Arizona, California, Maryland, Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.